Anti-Inhibitor Coagulant Complex: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Anti-Inhibitor Coagulant Complex. Educational only — not medical advice.
Labeled uses
FEIBA is an Anti-Inhibitor Coagulant Complex indicated for use in hemophilia A and B patients with inhibitors for: Control and prevention of bleeding episodes Perioperative management Routine prophylaxis to prevent or reduce the frequency of bleeding episodes. FEIBA is not indicated for the treatment of bleeding episodes resulting from coagulation factor deficiencies in the absence of inhibitors to coagulation factor VIII or coagulation factor IX.
Source: FDA labeling via NIH DailyMed (set 752604e5…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.